SCID Labs - EQA Registration
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
24 Apr 2025
Description
This is for the continued support of screening for Severe Combined Immunodeficiency (SCID) as part of the In-Service Evaluation (ISE). The seven regional newborn blood spot screening laboratories participating in the SCID ISE are: Great Ormond Street Hospital (GOSH) South West Thames South East Thames (Synnovis) Newcastle * Manchester Birmingham Sheffield * Newcastle lab's EQA tests the two SCID methodologies.
Scope
- Reference
- C348003
- Commercial tool
- Standalone contract
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Submission & procedure
- Procedure
- Below threshold - without competition
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded suppliers· 1 supplier
Awarded —
Other contracts from NHS England
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to GENQA LTD· 7
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Development of ABR peer review External Quality Assurance system | contract | — | 12 Jun 2026 |
| Development of ABR peer review External Quality Assurance system | contract | — | 23 Jan 2026 |
| Development of ABR peer review External Quality Assurance system | contract | — | 23 Jan 2026 |
| Development of ABR peer review External Quality Assurance system | contract | £280k | 04 Sept 2025 |
| Development of ABR peer review External Quality Assurance system | contract | — | 04 Sept 2025 |
| Genomics Training Assessment and Competence Tool (GTACT) | contract | — | 25 Apr 2022 |
| Genomics Training Assessment and Competence Tool (GTACT) | contract | £552k | 19 Apr 2022 |